Mortality in Psoriatic Arthritis – A Single-center Study from the UK

Buckley, Caitriona; Cavill, Charlotte; Taylor, Gordon; Kay, Hazel; Waldron, Nicola; Korendowych, Eleanor; McHugh, Neil

doi:10.3899/jrheum.100034

Cited by 71 publications

(60 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The SMR of antineutrophil cytoplasmic antibody-associated vasculitis ranged from 1.60 to 4.80 (36)(37)(38). The SMR of PsA patients was reported to be 1.62 in a cohort from the 1980s (32), but the SMR determined in the past decade was reported to be 0.56-0.82, i.e., not higher than that of the general population (30,31). Table 4 summarizes the SMRs for different rheumatic diseases found in different studies.…”

Section: Life Expectancy Smrs and Causes Of Death In Rheumatic Disementioning

confidence: 99%

Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China

Mok¹,

Kwok²,

Ho³

et al. 2011

Arthritis & Rheumatism

196

161

View full text Add to dashboard Cite

Objective. To examine the life expectancy, standardized mortality ratios (SMRs), and causes of death in 6 groups of patients from Hong Kong with different rheumatic diseases.Methods 7 years). In male patients, the loss in life expectancy was highest for SV (28.3 years), SLE (27 years), and SSc (16 years). There were 2,486 deaths during the study period (1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008), and the principal causes were infections (28%), cardiovascular complications (18%), cancer (16%), and disease activity (7%). Infection was the leading cause of death in SLE, RA, AS, and PsA, whereas deaths from disease-related activity and cardiovascular complications were most frequent in SSc. Cancer was the most common cause of death in SV. Conclusion.Our findings indicate that patients with SLE, RA, AS, PsA, SV, and SSc have increased mortality rates and reduced life expectancy. SLE has the highest adjusted SMR, and female SSc patients have the greatest loss in life expectancy. Infection is the leading cause of death, followed by cardiovascular complications and malignancies.

show abstract

Section: Life Expectancy Smrs and Causes Of Death In Rheumatic Disementioning

confidence: 99%

Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China

Mok¹,

Kwok²,

Ho³

et al. 2011

Arthritis & Rheumatism

196

161

View full text Add to dashboard Cite

show abstract

“…Противоречат указанным работам несколько исследований [25,26], в том числе и работа S. Kondratiouk и соавт. (2008), в которой не выявлено повышения частоты атеротром-боза у больных ПсА [26].…”

Section: Discussionunclassified

“…Из факторов риска авторы отметили наличие у больных повышения артериаль-ного давления и индекса массы тела по сравнению с общей популяцией при отсутствии изменений уров-ня общего холестерина и глюкозы крови [26]. Не было установлено повышение риска смерти у пациентов с ПсА в популяции Великобритании (1985-2007): из 453 больных умерли 37 [25].…”

Section: Discussionunclassified

“…В связи с этим мы сочли необходимым выполнить сравнительный анализ встречаемости ИБС, стенокар-дии и инфаркта миокарда с ожидаемыми популяцион-ными значениями и ожидаемыми значениями для больных АС (по данным европейских метаанализов) [22][23][24][25][26]. Сравнение частоты появления ИБС с при-менением log-rank Mantel-Cox test и log-rank test for trend показало различия между частотой появления ИБС у лиц без СпА, пациентов с АС и ПсА, p < 0,0001.…”

Section: результатыunclassified

See 1 more Smart Citation

The Risk of Coronary Artery Disease Development in Patients With Ankylosing Spondylitis (Bechterew’s Disease) and Psoriatic Arthritis: A 10-Year Prospective Follow-Up Study

Гайдукова¹,

Ребров²

2016

Klinicist

View full text Add to dashboard Cite

“…При ПсА значения стандартизованного показателя смертности составляют от 0,8 до 1,6 [15,27,28]. В целом, пациенты с ПcА имеют повышенный риск ССЗ, однако данные, касающиеся частоты мозгового инсульта, проти-воречивы [27,29].…”

Section: общие принципыunclassified

According to the Materials of the 2015/2016 New European League Against Rheumatism (Eular) Guidelines for Reducing Cardiovascular Risk in Patients With Inflammatory Arthritis: General Characterization and Discussion Problems

Попкова¹,

Новикова²

2018

rsp

View full text Add to dashboard Cite

According to the materials of the 2015/2016 new European League Against Rheumatism (EULAR) guidelines for reducing cardiovascular risk in patients with inflammatory arthritis. The authors identify three main principles of prevention of cardiovascular diseases in rheumatoid arthritis and other chronic inflammatory arthritis and provide a general characterization of the guidelines, by reviewing the discussion problems.

show abstract

Mortality in Psoriatic Arthritis – A Single-center Study from the UK

Abstract: These results suggest that mortality in our single-center PsA cohort is not significantly different from the general UK population. No increased risk of death was observed in this cohort.

Cited by 71 publications

References 24 publications

Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China

Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China

The Risk of Coronary Artery Disease Development in Patients With Ankylosing Spondylitis (Bechterew’s Disease) and Psoriatic Arthritis: A 10-Year Prospective Follow-Up Study

According to the Materials of the 2015/2016 New European League Against Rheumatism (Eular) Guidelines for Reducing Cardiovascular Risk in Patients With Inflammatory Arthritis: General Characterization and Discussion Problems

Contact Info

Product

Resources

About